e-learning
resources
Vienna 2012
Tuesday, 04.09.2012
Epidemiology and care research of lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Organization and results of the EGFR mutation Spanish quality control program
J. J. Gómez-Román, S. G. Iosu, B. Angulo, N. M. Montserrat, L. F. Servando (Santander, Pamplona, Madrid, Spain)
Source:
Annual Congress 2012 - Epidemiology and care research of lung cancer
Session:
Epidemiology and care research of lung cancer
Session type:
Poster Discussion
Number:
3138
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. J. Gómez-Román, S. G. Iosu, B. Angulo, N. M. Montserrat, L. F. Servando (Santander, Pamplona, Madrid, Spain). Organization and results of the EGFR mutation Spanish quality control program. Eur Respir J 2012; 40: Suppl. 56, 3138
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Rasch modelling for validation of Hindi version of abbreviated World Health Organization quality of life scale (WHOQOL-Bref) for assessment of health related quality of life in patients with pulmonary tuberculosis
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis II
Year: 2008
Rasch analysis for evaluating abbreviated World Health Organization quality of life questionnaire (WHOQOL-Bref) in north Indian patients with bronchial asthma
Source: Annual Congress 2011 - Asthma: a heterogeneous disease
Year: 2011
The effect of changes in quality of life in patients with lung cancer in the observation period (European Organization for Research and treatment of Cancer) EORTC QLQ-C 30 results of the evaluation and follow-up (AKAYAK-1 project)
Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life
Year: 2013
Health status (quality of life) of patients with COPD is improved by a specific educational program, Edu-Care
Source: Annual Congress 2004 - Outcome of pulmonary rehabilitation
Year: 2004
The World Health Organization global aDSM database: generating evidence on the safety of new treatment regimens for drug-resistant tuberculosis
Source: Eur Respir J, 51 (3) 1701643; 10.1183/13993003.01643-2017
Year: 2018
Resources and support of the World Health Organization to improve air quality
Source: International Congress 2019 – Is your patient dying from air pollution?
Year: 2019
Health economics of COPD: First results of the new German COSYCONET cohort compared to population-based controls from KORA
Source: International Congress 2014 – Highlights in respiratory epidemiology
Year: 2014
Health status measurements in alpha-1antitrypsin deficiency (AATD)
Source: International Congress 2015 – Monitoring airway diseases with lung function tests
Year: 2015
Update on asthma control in five European countries: results of a 2008 survey
Source: Eur Respir Rev 2009; 19: 150-157
Year: 2010
External quality assessment (EQA) for laboratory diagnosis of alpha1-antitrypsin deficiency (AATD) – Program driven by the European Alpha-1-Research Collaboration (EARCO) network
Source: Virtual Congress 2021 – Pathogenic progress in airway diseases
Year: 2021
Assessment of asthma control based on French guidelines criteria. Results from a pharmacy-based study
Source: Eur Respir J 2006; 28: Suppl. 50, 684s
Year: 2006
Validation of asthma quality of life questionnaire: Brazilian version
Source: Eur Respir J 2006; 28: Suppl. 50, 843s
Year: 2006
World Health Organization treatment outcome definitions for tuberculosis: 2021 update
Source: Eur Respir J, 58 (2) 2100804; 10.1183/13993003.00804-2021
Year: 2021
The assessment of the effect of changes in lung cancer follow-up period to the quality of life by using EQ-5D questionnaire and follow data (the project of AKAYAK-1)
Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life
Year: 2013
Comparison of quality of life scores with modified Medical Research Council (mMRC) dyspnoea scale using data from the European health-related quality of life study
Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation
Year: 2012
Assessment of responsiveness to the German translation of the ²marks‘ asthma quality of life questionnaire²
Source: Annual Congress 2004 - Asthma and perceived health status
Year: 2004
European mapping of EGFR mutation test and EGFR tyrosine kinase inhibitors availability in thoracic oncology
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015
The new World Health Organization classification of lung tumours
Source: Eur Respir J 2001; 18: 1059-1068
Year: 2001
Applicability of the World Health Organization recommended new shorter regimen in a multidrug-resistant tuberculosis high burden country
Source: Eur Respir J 2017; 49(1): 1601967; DOI: 10.1183/13993003.01967-2016
Year: 2017
FACT-L (functional assessment of cancer therapy-lung) psychometric properties of the Turkish version of quality of life scale (validity and reliability) and determination using the clinic (Akkaya-1 project)
Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept